Professional Profile
Mr. Beck Miller is Director of the BlueRidge Life Sciences Pharmaceutical Commercialization practice. He is a strategic health economics and outcomes research (HEOR) leader with extensive experience developing and managing cost-effectiveness, budget impact, and cost-consequence models to support global market access. With a proven track record leading cross-functional projects supporting engagement with HTA bodies (NICE, ICER, BeneLuxa, Nordics), Mr. Miller delivers evidence-based insights that strategically inform commercial decisions and evidence-generation activities. He is adept at client engagement and translating complex analyses into succinct, actionable strategies for diverse stakeholders.
In his previous roles as an associate director and research scientist, Mr. Miller has significant experience developing and programming advanced HEOR models, including model design, client engagement, and strategic support during ICER reviews and HTA submissions. He is able to both independently and collaboratively develop health economic models using Excel and VBA for submissions. Other expertise includes managing cost-effectiveness, cost-consequence, and budget impact models to ensure methodological rigor and alignment with HTA and payer requirements, and utilizing R to conduct model analyses.
As a leader in his field, Mr. Miller has served as a HEOR representative in cross-functional initiatives, integrating modeling insights into broader strategy. He has directed and supervised HEOR modeling projects with multiple team members, helping to foster collaboration and skills development, while simultaneously establishing strategic client partnerships and presenting model frameworks tailored for decision making across diverse stakeholders. He has disseminated his work through publications in peer-reviewed journals and presentations at a variety of scientific conferences.